Welcome to Catalonia’s Hub for Advanced Therapies
Powered by Biocat, ATMP Catalonia is a leading European network driving cell and gene therapies from lab to patient. With a strong commitment to scientific excellence, strategic collaboration and patient access, we turn cutting edge science into real world health outcomes, making Catalonia one of the most collaborative advanced therapies hub in Europe.
Our vision is to shape the future of cell and gene therapies by fostering a connected, dynamic, resilient hub. From cutting edge research to industrial scaleup, we aim to establish Catalonia as a European benchmark for accelerating innovation and improving patient access to advanced therapies.
Discover Catalonia’s network driving innovation in advanced therapies and real patient impact.
An ecosystem driving advanced therapies from research to care
By building community,
we build health.
ATMP Catalonia is a broad and expanding network where research centers, hospitals, manufacturers, pharma companies, startups, service providers and suppliers come together to share knowledge, infrastructure and opportunities, maximizing synergies and accelerating impact.
The ATMP Catalonia community has the clinical, scientific, technological and industrial expertise to cover every stage of the advanced therapies value chain.
In figures
In Europe for ATMP publications
and highly cited papers
Raised by Catalan startups
in advanced therapies
Catalonia’s impact in advanced therapies
In Europe for ATMP publications
and highly cited papers
Advanced therapies
preclinical assets in development
Raised by Catalan startups
in advanced therapies
News & Events
What’s driving innovation
in advanced therapies
ATMP Series: Biomanufacturing
ATMP Catalonia Series: From Preclinical Discovery to First-in-Human Trials
Follow the science, stories and people turning advanced therapies into real world impact
